A grande vantagem face aos anticorpos que agora são usados no combate à doença é que por ser pequena, esta molécula penetra por completo no tumor e os custos são bem mais baratos.
Falta ainda passar aos ensaios em humanos para validar o tratamento e só depois, se tudo correr conforme os investigadores esperam, é que avançará a produção industrial.
Este website usa cookies para melhorar a experiência do utilizador. Quando fechar esta mensagem confirma que concorda com o seu uso.AceitarLer mais
Política de Privacidade & Cookies
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
